Harvard Bioscience
HBIO
$0.84
Share price
-1.14%
Change (1 day)
-84.94%
Change (1 year)
Categories
Revenue for Harvard Bioscience (HBIO)
Revenue in 2024 (TTM): C$0.13 Billion
According to Harvard Bioscience's latest financial reports the company's current revenue (TTM 
) is C$0.13 Billion. In 2023 the company made a revenue of C$0.14 Billion a decrease over the revenue in the year 2022 that were of C$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Harvard Bioscience from 2000 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | C$0.13 B | -11.45% |
| 2023 | C$0.14 B | -3.19% |
| 2022 | C$0.15 B | 1.49% |
| 2021 | C$0.15 B | 16.4% |
| 2020 | C$0.13 B | -14.2% |
| 2019 | C$0.15 B | -7.77% |
| 2018 | C$0.16 B | 57.23% |
| 2017 | C$0.10 B | -25.51% |
| 2016 | C$0.14 B | -6.82% |
| 2015 | C$0.15 B | 19.54% |
| 2014 | C$0.12 B | 12.64% |
| 2013 | C$0.11 B | 1.27% |
| 2012 | C$0.11 B | -0.17% |
| 2011 | C$0.11 B | 2.4% |
| 2010 | C$0.10 B | 19.82% |
| 2009 | C$90.24 M | -15.7% |
| 2008 | C$0.10 B | 28.67% |
| 2007 | C$83.2 M | -6.19% |
| 2006 | C$88.69 M | 12.98% |
| 2005 | C$78.5 M | -23.89% |
| 2004 | C$0.10 B | -8.75% |
| 2003 | C$0.11 B | 24.73% |
| 2002 | C$90.62 M | 39.2% |
| 2001 | C$65.1 M | 42.13% |
| 2000 | C$45.8 M |